SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-055006
Filing Date
2020-05-01
Accepted
2020-05-01 08:32:44
Documents
20
Period of Report
2020-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2018208d1_6k.htm 6-K 11563
2 EXHIBIT 99.1 tm2018208d1_ex99-1.htm EX-99.1 21150
3 GRAPHIC ex99-1_graph.jpg GRAPHIC 10283
4 EXHIBIT 99.2 tm2018208d1_ex99-2.htm EX-99.2 21324
5 GRAPHIC image_001.jpg GRAPHIC 92231
6 GRAPHIC image_002.jpg GRAPHIC 446498
7 GRAPHIC image_003.jpg GRAPHIC 333432
8 GRAPHIC image_004.jpg GRAPHIC 237015
9 GRAPHIC image_005.jpg GRAPHIC 44211
10 GRAPHIC image_006.jpg GRAPHIC 222454
11 GRAPHIC image_007.jpg GRAPHIC 220108
12 GRAPHIC image_008.jpg GRAPHIC 228665
13 GRAPHIC image_009.jpg GRAPHIC 220180
14 GRAPHIC image_010.jpg GRAPHIC 221547
15 GRAPHIC image_011.jpg GRAPHIC 210683
16 GRAPHIC image_012.jpg GRAPHIC 139028
17 GRAPHIC image_013.jpg GRAPHIC 218117
18 GRAPHIC image_014.jpg GRAPHIC 253089
19 GRAPHIC image_015.jpg GRAPHIC 257583
20 GRAPHIC image_016.jpg GRAPHIC 92231
  Complete submission text file 0001104659-20-055006.txt   4799953
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 20838518
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences